Sign In
Buy AVRO
$1.40
+0 (+0%)
At Close: Sep 19, 2024
The
AVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis
11:00am, Wednesday, 13'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced new clinical data from its investigational
AVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis
12:00am, Wednesday, 13'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an
Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
12:00am, Monday, 11'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transform
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Catalent, Inc. (CTLT) CEO John Chiminski on Q3 2020 Results - Earnings Call Transcript
03:20pm, Saturday, 09'th May 2020
Catalent, Inc. (NYSE:CTLT) Q3 2020 Earnings Conference Call May 5, 2020 08:15 ET Company Participants Paul Surdez - Vice President, Investor Relations John Chim
We're Not Very Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Rate
12:36pm, Saturday, 09'th May 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Why Earnings Season Could Be Great for AVROBIO (AVRO)
12:42pm, Friday, 08'th May 2020
AVROBIO (AVRO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Avrobio Magenta Collaboration, And Other News: The Good, Bad And Ugly Of Biopharma
06:44pm, Thursday, 07'th May 2020
Avrobio and Magenta will collaborate on a novel ADC. Adverum reports positive wet AMD data. AstraZeneca's Farxiga is approved.
AVROBIO Reports 1Q 2020 Financial Results and Provides Business Update
11:00am, Thursday, 07'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported financial results for the quarter ended Mar
AVROBIO Reports 1Q 2020 Financial Results and Provides Business Update
12:00am, Thursday, 07'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today re
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:05pm, Wednesday, 06'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted non-statutory
AVROBIO, Inc. (Nasdaq: AVRO) and Magenta Therapeutics (Nasdaq: MGTA) today announced a research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, Magenta’s novel ta
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company, along with its academic
